Wealth Management Associates, Inc.
Source: SEC Form 13F · as of Mar 2026Wealth Management Associates, Inc. holds 20 biotech & pharma companies tracked by BioSniper, totaling $15.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$15.3M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 2,755 | $2.5M |
| JNJJOHNSON & JOHNSON | 10,229 | $2.5M |
| PFEPFIZER INC | 61,767 | $1.7M |
| ABBVAbbVie Inc. | 6,506 | $1.4M |
| MRKMerck & Co., Inc. | 11,339 | $1.4M |
| BBIOBridgeBio Pharma, Inc. | 9,035 | $671K |
| CORCencora Inc. | 1,890 | $594K |
| ABUSArbutus Biopharma Corp | 131,870 | $593K |
| CAHCardinal Health Inc. | 2,720 | $575K |
| IBRXImmunityBio, Inc. | 60,700 | $466K |
| PMPhilip Morris International Inc | 2,285 | $378K |
| GILDGILEAD SCIENCES, INC. | 2,585 | $360K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,324 | $358K |
| AZNASTRAZENECA PLC | 1,780 | $351K |
| ABTABBOTT LABORATORIES | 3,358 | $345K |
| ARGXARGENX SE | 384 | $280K |
| BMYBRISTOL MYERS SQUIBB CO | 3,958 | $240K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,129 | $228K |
| AMGNAMGEN INC | 599 | $211K |
| SGMOSANGAMO THERAPEUTICS, INC | 295,800 | $73K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.